61 related articles for article (PubMed ID: 1776848)
1. Flow cytometric and immunohistochemical analysis of p62c-myc oncoprotein in the bronchial epithelium of lung cancer patients.
Sundaresan V; Reeve JG; Wilson B; Bleehen NM; Watson JV
Anticancer Res; 1991; 11(6):2111-6. PubMed ID: 1776848
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.
De Santis L; Mangili F; Sassi I; Di Rocco M; Rossi C; Cantaboni A
Anal Cell Pathol; 1995 Apr; 8(3):247-57. PubMed ID: 7547497
[TBL] [Abstract][Full Text] [Related]
3. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
[TBL] [Abstract][Full Text] [Related]
4. [DNA content analysis and detection of c-myc and p53 products using flow cytometry in resected lung cancer cases].
Chiba W; Sawai S; Ikeda S; Morimoto K; Wazawa H; Hanawa T; Yamashita N; Matsui T; Hatakenaka R; Matsubara Y
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():108-16. PubMed ID: 8203922
[TBL] [Abstract][Full Text] [Related]
5. Use of the OM-11-906 monoclonal antibody for determining p62 c-myc expression by flow cytometry in relation to prognosis in colorectal cancer.
Rowley S; Carpenter R; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
Eur J Surg Oncol; 1991 Aug; 17(4):370-8. PubMed ID: 1874294
[TBL] [Abstract][Full Text] [Related]
6. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
7. [Nuclear oncoprotein expression in lung precancer and cancer at various stages of tumor progression studies at the level of light- and electron-immunohistochemistry].
Kogan EA; Shtabskiĭ AB; Sekamova SM; Mazurenko NN; Kiselev FL
Arkh Patol; 1994; 56(6):44-9. PubMed ID: 7605217
[TBL] [Abstract][Full Text] [Related]
8. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
9. [C-myc activation by translocation in human primary non-small cell lung cancer].
Lu Y; Cheng S; Guo S
Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):275-7. PubMed ID: 8758273
[TBL] [Abstract][Full Text] [Related]
10. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
11. c-myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumours.
Rew DA; Taylor I; Cox H; Watson JV; Wilson GD
Br J Surg; 1991 Sep; 78(9):1080-3. PubMed ID: 1933191
[TBL] [Abstract][Full Text] [Related]
12. [Expression of P62c-myc protein in breast cancer and its clinical significance].
Yang J; Zhou L; Hu R; Zhao J; Yao X; Long Q; Fan W; Chen L; Xing T
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Dec; 29(4):399-401. PubMed ID: 10743237
[TBL] [Abstract][Full Text] [Related]
13. Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma.
Spandidos DA; Kaloterakis A; Yiagnisis M; Varatsos A; Field JK
Anticancer Res; 1990; 10(6):1619-25. PubMed ID: 1980998
[TBL] [Abstract][Full Text] [Related]
14. [Positive expression of c-myc and p53 products in two cases of pulmonary sclerosing hemangioma].
Chiba W; Sawai S; Yasuda Y; Wazawa H; Matsubara Y; Ikeda S
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33(12):1348-54. PubMed ID: 8821986
[TBL] [Abstract][Full Text] [Related]
15. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
[TBL] [Abstract][Full Text] [Related]
16. [Amplification of the expression of the c-myc oncogene in bronchial epidermoid carcinoma in man].
Douc-Rasy S; Terrier P; Kemeny JL; Amouroux J; Riou G
C R Acad Sci III; 1985; 301(13):621-6. PubMed ID: 3937573
[TBL] [Abstract][Full Text] [Related]
17. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
Anticancer Res; 1995; 15(3):959-64. PubMed ID: 7645986
[TBL] [Abstract][Full Text] [Related]
19. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
[TBL] [Abstract][Full Text] [Related]
20. erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients.
Breuer B; De Vivo I; Luo JC; Smith S; Pincus MR; Tatum AH; Daucher J; Minick CR; Miller DG; Nowak EJ
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):63-6. PubMed ID: 7906981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
